Mediators of Inflammation / 2013 / Article / Fig 7

Research Article

Dose-Dependent Anti-Inflammatory and Neuroprotective Effects of an ανβ3 Integrin-Binding Peptide

Figure 7

C16 treatment ameliorated the disease progression and alleviated the disease severity. ((a)–(c)) The clinical progression of EAE was attenuated after medium (b) and high (c) dose C16 applications. versus vehicle treated group at the same time point. versus vehicle treated group at the same time point. (d) The clinical progression of EAE was attenuated by the C16 late treatment. versus vehicle treated group at the same time point.
268486.fig.007a
(a)
268486.fig.007b
(b)
268486.fig.007c
(c)
268486.fig.007d
(d)

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.